SKSanjeev Kishore

Sanjeev Kishore

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sanjeev Kishore has a total of 67 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Bridging the Gap Between Endoscopy and Histology Indices: A Multi-Index Comparison in 146 Ulcerative Colitis Patients

    by Zahed Ali Qamer, Prashant Durgapal, Arvind Kumar, Ashok Singh, Itish Patnaik, Sanjeev Kishore, Ravi Hari Phulware

    Background: Ulcerative Colitis (UC) is a chronic inflammatory bowel disease affecting the colonic mucosa, with a relapsing-remitting course. Disease activity is assessed using clinical, serologic, endoscopic, and histological parameters, among which the latter two remain the cornerstone for assessing disease severity and therapeutic response. However, limited studies have evaluated the correlation between endoscopic and histological activity. This study evaluates the correlation between the Mayo endoscopic score (MES) and validated histological indices, namely the Geboes score (GS), Nancy index (NI), and Robarts histological index (RHI), to determine the most practical and reliable histological scoring system. Methods: This cross-sectional study was conducted over a period of two and a half years at a tertiary care hospital in North India and included 146 established UC patients. Colonoscopic evaluation was performed by a single gastroenterologist, and biopsies were obtained from areas showing the highest possible MES. Subsequent histopathological examination and scoring using the histological indices (GS, NI, and RHI) were performed independently by pathologists masked to the endoscopic findings. Correlations were assessed using the Chi-Square test and Spearman's rho to evaluate relationships between endoscopic and histopathological scores. Results: A total of 146 biopsies were analyzed, with a median patient age of 34 years; male patients constituted 56% of patients, and the recto-sigmoid region was the most commonly affected site (62%). Moderate (50%) and severe (32%) endoscopic aspects suggestive of UC activity were predominant. Correlation coefficients between MES and GS/RHI/NI were moderate (rho = .617/.622/.599, respectively; P < .001 for all three correlations). The NI was the fastest to evaluate and demonstrated a similar correlation with the MES compared to the GS and RHI. Conclusion: A moderate yet consistent correlation was observed between the MES and all three histopathological indices, highlighting their reliability in reflecting disease severity and supporting their interchangeable use in routine practice. Among them, the NI emerged as the most practical and user-friendly scoring system due to its simplicity and rapid applicability, while maintaining diagnostic performance comparable to the GS and RHI.

  • Open Access

    Targeting Human Epidermal Growth Factor Receptor 2 in Bladder Cancer: Evaluating Its Role as a More Robust Clinicopathological Biomarker Compared to Programmed Death Ligand 1 Expression

    by Ankur Mittal, Kunal Malhotra, Vikas Panwar, Sanjeev Kishore, Mohammed Taher, Avin Singhal

    Objective: This retrospective cross-sectional analytical study evaluated the clinicopathological associations of programmed death ligand 1 (PD-L1) and human epidermal growth factor receptor 2 (HER2/neu) expression in 250 patients with urothelial carcinoma of the urinary bladder, with particular emphasis on their relationship to tumor stage and lymph node involvement. Methods: A retrospective observational study was conducted on 250 patients with urothelial carcinoma who underwent immunohistochemical evaluation of PD-L1, using a tumor proportion score (TPS) of ≥1%, and HER2/neu with 3+ considered positive. Formalin-fixed paraffin-embedded tissue from transurethral resection of bladder tumor and cystectomy specimens was analyzed by immunohistochemistry. The HER2/ neu was scored using a standard 0-3+ system, and PD-L1 expression was assessed by TPS. Associations were tested using chi-square or Fisher’s exact tests. Multivariable logistic regression evaluated whether HER2/neu independently predicted nodal involvement after adjustment for age, sex, tumor stage, and morphology. Statistical significance was set at P < .05. Results: The HER2/neu 3+ positivity was present in 100/250 patients (40%) and was significantly associated with nodal involvement (P = .019). On multivariable logistic regression, HER2/neu is independently associated with nodal involvement, reflecting aggressive tumor biology (adjusted OR 2.41; 95% CI 1.33-4.36; P = .004). Among node-negative patients (N0, n = 200), 35.5% were HER2/neu positive, rising stepwise to 50.0% in N1, 54.5% in N2, and 71.4% in N3 disease, supporting a relationship between HER2/ neu overexpression and nodal progression. In contrast, PD-L1 positivity (TPS ≥1%) was observed in 129/250 patients (51.6%) and was not significantly associated with age, sex, tumor stage, nodal status, grade, multiplicity, or morphology (all P > .05). Conclusion: The HER2/neu was an independent clinicopathological biomarker associated with nodal involvement and aggressive tumor biology in urothelial carcinoma. PD-L1 showed limited clinicopathological utility in this cohort, though it retains predictive value for immune checkpoint inhibitor therapy. Cite this article as: Mittal A, Malhotra K, Panwar V, Kishore S, Taher M, Singhal A. Targeting human epidermal growth factor receptor 2 in bladder cancer: evaluating its role as a more robust clinicopathological biomarker compared to programmed death ligand 1 expression. Urol Res Pract. 2026, 52, 0061, doi: 10.5152/tud.2026.25061.

  • Investigating Renal Papillary Adenoma: Identifying the Associated Conditions Through the Vigilant Lens of the Pathologist!

    by Pakesh Baishya, Ravi Hari Phulware, Ashok Singh, Prashant Durgapal, Ankur Mittal, Sanjeev Kishore, Arvind Kumar

    Renal papillary adenoma (RPA) is a rare benign tumor that is usually asymptomatic and incidentally detected. Although typically benign and of low malignant potential, close monitoring and further investigation is warranted due to the potential association with renal cell carcinoma and other associated conditions as per the present literature. We performed a clinicopathological evaluation of incidentally detected renal papillary adenomas to ascertain features having a prognostic impact along with the systematic review of literature. All cases of incidentally detected RPA of the kidney from January 2019 to December 2022 were assessed for size, site of adenomas, clinical features, associated conditions, clinical diagnosis, and a number of adenomas. Each feature was noted and correlated with the associated conditions of the patient and prognosis. We received a total of 62 nephrectomies, in the Department of Pathology, AIIMS Rishikesh, for non-functioning kidneys from January 2019 to December 2022, four cases exhibit incidentally detected renal papillary adenoma. Medical renal biopsies received during the period were 330 in number and only one case shows renal papillary adenoma along with IgA nephropathy and focal segmental glomerulosclerosis (FSGS) lesion. The association of both entities is unclear in the medical literature and is a rare finding. Two cases of chronic pyelonephritis demonstrate multiple adenomas of varying sizes and one was associated with hepatitis B virus infection. Our study outlines histomorphology spectrum of incidentally detected RPA and emphasizes its frequent occurrence in patient undergoing nephrectomies for non-functioning end-stage kidney diseases and rare association of IgA nephropathy. Limitation of the study was a small number of cases with follow-up.

  • Study of Immunoexpression of Autophagy Markers- LC3A And LC3B in Cervical Squamous Cell Carcinoma and its Clinicopathological Correlation

    by Vinay N. Gowda, Prashant Durgapal, Anupama Bahadur, Sanjeev Kishore

    Cancer remains a challenge in terms of a cure. The invention of new modalities targeting various pathogenesis related to tumorigenesis has become the latest hot topic of research worldwide. In developing countries, cervical cancer remains one of the most important causes of mortality in women worldwide after breast cancer. Autophagy is a physiological process of intracellular degradation of cytoplasmic components within lysosomes and has been implicated in maintaining homeostasis. Under altered biological/metabolic conditions such as cellular stress, autophagy plays a vital role in cell survival or death. It represents an alternative tumour-suppressing mechanism to overcome the resistance of many cancers to chemotherapy. Microtubule-associated protein-1 light chain-3 (MAP1LC3) gene plays a pivotal role in autophagy, comprising of a soluble LC3A and a non-soluble form LC3B correlating with autophagy after being recruited into autophagosomes, thus considered as a reliable marker in the detection of autophagy. We have done a retrospective archived tissue study on cervical cancer biopsy specimens to study the immunoexpression of autophagy markers LC3A and LC3B and their correlation with clinicopathological parameters. Targeted manipulation of autophagy will provide therapeutic avenues for designing optimal therapeutic strategies in cancer therapy.

  • Open Access

    Differences in the Expression of Autophagy Markers Microtubule-Associated Protein Light Chains 3A and 3B in Oral Premalignant Lesions and Oral Squamous Cell Carcinoma: A Cross-Sectional Study

    by Tulika Wakhloo, Prashant Durgapal, Nilotpal Chowdhury, Srinivas Reddy, Ashi Chug, Sanjeev Kishore

    Background Microtubule-associated protein light chains (LC) 3A and 3B are the structural proteins of the autophagosomal membrane widely used as endogenous autophagy markers. LC3A and LC3B autophagosomes reportedly have a distinct subcellular localization yet their role in the transition from premalignant to malignant phase remains unclear. This exploratory study aimed to investigate the expression of autophagy-related proteins LC3A and LC3B in oral premalignant lesions (OPL) and oral squamous cell carcinoma (OSCC) cases. Methodology A cross-sectional study was conducted on 100 OPL and 39 OSCC samples. OPL samples comprised both dysplastic and non-dysplastic lesions. The expression of LC3A and LC3B markers was evaluated in the study samples using immunohistochemistry and associated with dysplasia in OPL and with invasive OSCC versus OPL. Fisher's exact test was used for statistical analysis. Results There was a higher ratio of LC3A positivity in non-dysplastic OPL (31/38) compared to dysplastic premalignant lesions (36/62, p=0.017). There was a higher ratio of LC3B positivity in dysplastic OPL (16/62) compared to non-dysplastic lesions (4/38) with a trend towards statistical significance (p=0.075). There was no statistical difference in the ratio of LC3A positivity between OSCC (23/39) and premalignant (67/100) lesions, while the ratio of LC3B marker positivity was higher in OSCC cases (18/39) relative to premalignant lesions (20/100, p=0.003). Conclusion Autophagy-related proteins LC3A and LC3B may have different roles to play in a disease context manner. LC3A is likely to be negatively associated with dysplasia in OPL while LC3B expression is positively associated with carcinogenesis of OSCC, possibly including dysplasia.

  • Histomorphological Spectrum of Ovarian Tumours in a Tertiary Care Centre of North India: A Case Series

    by Sana Ahuja, Michael Leonard Anthony, Arvind Kumar, Prashant Durgapal, Prashant Joshi, Shalinee Rao, Sanjeev Kishore, Ashok Singh

    Ovarian tumours constitute the second most common tumour of the female genital tract after cervical cancers. The study describes the histological subtypes of ovarian neoplasms along with other parameters like age, laterality and consistency of lesion in a tertiary care centre in Uttarakhand. The retrospective data of ovarian tumours sent to the Department of Pathology was collected over a period of 4.5 years. They were classified into benign, borderline and malignant categories in the respective histological subtypes (surface epithelial, germ cell, sex cord stromal and metastatic) based on the latest WHO classification. The consistency of tumour, laterality and age of the patient were also evaluated. Of the 130 cases studied, 73 (56%) were benign, 13 (10%) were borderline and 44 (34%) were malignant. The majority of cases (73.1%) were surface epithelial tumours, followed by germ cell tumours (20.8%), sex cord stromal tumours (4.6%) cases and metastatic tumours (1.6%). Most cases (80.8%) showed unilateral involvement while 19.2% cases had bilateral involvement. The majority of cases in the present study were benign. Serous cystadenoma was the most common benign tumour with its malignant counterpart being the most common tumour in the malignant category.

  • A Study of Ki-67 Immunostaining in Prostate Carcinomas and Its Correlation with Gleason’s Score and Prognosis: An Experience at a Tertiary Centre in the Himalayan Foothills

    by Nishi Jha, Ravi Hari Phulware, Arvind Kumar, Ashok Singh, Prashant Durgapal, Nilotpal Chowdhury, Ankur Mittal, Sanjeev Kishore

    Prostate cancer is a significant cause of cancer-related mortality among men worldwide, necessitating the exploration of prognostic biomarkers to aid in accurate risk assessment and treatment decision-making. This cross-sectional study aimed to comprehensively evaluate the role of Ki-67 as a prognostic marker in prostate cancer by examining its association with clinicopathological parameters. A total of 102 archived cases of prostate core biopsy specimens, histopathologically reported as prostate carcinoma, were included in this study. Histopathological grading was conducted using Gleason’s scoring and grading system based on morphology. The statistical software “R” was utilized for data analysis. Kruskal–Wallis test and Fisher’s exact test were employed to analyze the association between Ki-67 expression and clinicopathological parameters. The study revealed significant correlations between Ki-67 expression and various clinicopathological parameters in prostate cancer cases. High Ki-67 expression levels were associated with higher Gleason scores, increased incidence of perineural invasion, advanced T stages, lymph node metastasis, presence of distant metastasis, and higher prognostic stage groups. The findings of this cross-sectional study support the potential of Ki-67 as a prognostic marker in prostate cancer. The significant associations observed between Ki-67 expression and clinicopathological parameters indicate its usefulness in risk stratification and treatment decision-making. The incorporation of histopathological grading, including Gleason scoring, and analysis of perineural invasion strengthens the validity of the study. Ki-67, in combination with morphological assessments, provides valuable prognostic information for prostate cancer patients.


  • Open Access

    Primary Malignant Melanoma of the Oral Cavity: A Retrospective Study From a Tertiary Care Centre of North India

    by Kavya Udyavar Raviraj, Sonali Mishra, Aishwarya Chandra, Anupa Khanal, Nishi Jha, Arvind Kumar, Ravi Hari Phulware, Ashok Singh, Prashant Durgapal, Prashant Joshi, et al.

    Background: Mucosal melanoma is a rare but aggressive tumor associated with a poor prognosis arising from pigmented cells called melanocytes. They are usually asymptomatic and present in an advanced stage. It has an aggressive clinical outcome and is proven to be of poor prognosis. Materials and methods: This is a retrospective review of the computer database and clinical records at the All India Institute of Medical Sciences, Rishikesh, India. The data between 2018-2022 were reviewed for all small biopsy or excision specimen-proven cases of oral mucosal melanoma. Results: The most common site of involvement in the head and neck region is the nasal cavity and paranasal sinuses. In this retrospective study from our institute, all three cases presented involved oral cavities. The median age of presentation was 51 years. Some literature specifies male preponderance. Our patients presented clinically with a black nodule in the oral cavity, which was increasing in size and associated with bleeding. A biopsy performed confirmed the diagnosis of melanoma based on the morphology and immunohistochemical profile of the tumor cells. Conclusion: Surgical resection is the mainstay treatment, followed by radiation postoperatively to reduce local and regional recurrence. Mucosal melanoma has a poor prognosis, and the majority of patients develop incurable metastatic disease.


  • Open Access

    Efficacy of Ferulic Acid in an Animal Model of Drug-Resistant Epilepsy: Beneficial or Not?

    by Surabhi Thapliyal, Jagjit Singh, Mukesh Mamgain, Ashish Kumar, Manisha Bisht, Ashok Singh, Kiran Meena, Sanjeev Kishore, Shailendra Handu

    Lamotrigine (LTG) and subconvulsive doses of pentylenetetrazol (PTZ) as a model mimic drug-resistant epilepsy (DRE), which is a serious unmet medical condition. Previous evidence suggests an imperative role of neuroinflammation in the development of DRE. Various preclinical models of brain injury have reported potent anti-inflammatory and antioxidant properties of ferulic acid (FA). Therefore, its efficacy against intractable epilepsy is worthwhile to study. The present study evaluated the efficacy of FA in LTG and PTZ-induced refractory seizures in mice. On every alternate day for 38 days, LTG (5mg/kg) was injected before PTZ (30-40mg/kg) to establish a murine model of DRE. Animals were treated with two doses of FA (40, 80 mg/kg). All the animals were assessed for seizure score and the latency of seizures every alternate day till the end of the study. Histopathological score and the levels of pro-inflammatory mediators, interleukin-1βeta (IL-Iβ), tumor necrosis factor-alpha (TNF-α), and matrix metalloproteinase-9 (MMP-9) were quantified in the brain tissue of these mice. Ferulic acid (FA) neither decreases the LTG and PTZ-induced refractory seizures score nor increases the latency to develop seizures. In addition, the injury to hippocampal neurons and the levels of pro-inflammatory cytokines were comparable with two doses of FA in treated mice. In the present study, single-dose FA treatment does not show any beneficial effect against the LTG/PTZ model of DRE. Therefore, its single-dose administration might not be beneficial against the DRE model.


  • A Clinicopathological Correlation of Bladder Cancer in Young and Old Patients: Our Experience and Review of Literature

    by Harkirat Singh Talwar, Vikas Kumar Panwar, Ankur Mittal, Sanjeev Kishore, Arup Kumar Mandal

    To compare the clinical, cystoscopic, and pathological characteristics of bladder cancer in patients younger than 40 years of age and those of patients older than 40 years of age. We conducted a prospective observational study at our department from September 2019 to February 2021 to compare the clinico-pathological characteristics of young and old patients with biopsy proven bladder cancer after a transurethral resection of bladder tumour. The patients were managed according to standard guidelines. Two hundred sixty-eight patients of bladder cancer were included in the analysis. Out of these, 58 patients were < 40 years of age and 210 were > 40 years. The mean age of two groups were 31.43 ± 6.30 vs 59.08 ± 9.87 years. With respect to tumour grade, 36.2% (versus 17.6%) of young patients had low grade tumour, and 58.6% had high-grade tumour (versus 82.4%). In the young population, 63.8% patients had NMIBC (versus 61.9%) and 36.2% had MIBC (versus 38.1%). Even in the NMIBC group, a large majority of young patients had high-risk disease (51.4%). The incidence of bladder cancer is on the rise in the northern belt of India, especially in the younger age group. High exposure to smoke and heavy metals in drinking water/occupation are the major risk factors. Majority of young patients aged < 40 years had a high-grade disease on presentation and a large subset had muscle invasive bladder cancer, contrary to previously reported studies.